Clopidogrel Tablets Recalled Due to Mislabeling
One lot of clopidogrel, a platelet inhibitor, has been recalled due to mislabeling.
One lot of clopidogrel, a platelet inhibitor, has been recalled due to mislabeling.
The American College of Cardiology released an expert consensus decision pathway intended to guide clinicians in managing bleeding in patients treated with anticoagulation.
A recall has been issued for one lot of amiodarone due to possible particulate matter introduced into the solution.
The researchers concluded abacavir-containg ART does not increase the risk of coronary artery disease or myocardial infarction
Women with atrial fibrillation and diabetes have higher rates for mortality and cardiovascular disease compared to men.
Patients diagnosed with new atrial fibrillation after ischemic stroke were more likely to have preexisting cardiovascular comorbidities such as hypertension, heart failure, and coronary artery disease.
Patients treated with zoledronic acid had a higher risk for atrial fibrillation and other arrhythmias as well as heart failure vs untreated patients.
Platelet aggregation levels did not predict cardiovascular events in patients with stable coronary artery disease.
Initiation of insulin therapy in patients with type 2 diabetes was associated to inactivity and weight gain.
Most pharmacotherapies appear not to have significant effect on all-cause or cardiovascular mortality in heart failure with preserved ejection fraction.